Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    MaxAn
Show Display Options
Rank Status Study
1 Active, not recruiting MaxAn Post Market Surveillance Validation
Conditions: DDD;   Deformity;   Tumor;   Fracture
2 Active, not recruiting Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)
Condition: Cervical Disc Degenerative Disorder
Intervention: Biological: Cellentra VCBM

Indicates status has not been verified in more than two years